DHR vs WAT: fair value comparison
Danaher Corporation and Waters Corporation · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, WAT currently sits closer to the top of our ranking by discount to fair value.
| DHR | WAT | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $219.81 | $433.77 |
| 12-month range | $161.91–$242.05 | $283.32–$444.15 |
| Rank by discount to fair value | #55 of 108 Healthcare | #54 of 108 Healthcare |
| Quality grade | B | B |
| Leverage | Moderate | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | High |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: DHR fair value analysis · WAT fair value analysis